New drug trial targets Language-Loss dementia
Disease control
Not yet recruiting
This study is testing an experimental drug called NS101 for people with a rare type of dementia that primarily affects language, called semantic variant primary progressive aphasia (svPPA). The main goal is to see if the drug is safe and how the body processes it, while also look…
Phase: PHASE2 • Sponsor: Hee-Jin Kim • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC